Top compounds associated with response to OR51E1


Feature Type Standardized
Nominal ANOVA
mRNA paclitaxel CCLE pan-cancer AAC -0.081 0.07
mRNA AG-014699 GDSC1000 pan-cancer AAC -0.061 0.07
mRNA ZM-447439 GDSC1000 pan-cancer AAC -0.065 0.07
mRNA Erlotinib CCLE pan-cancer AAC -0.08 0.07
mRNA BRD-K17060750 CTRPv2 pan-cancer AAC 0.066 0.07
mRNA BRD9876:MK-1775 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 0.07
mRNA Gemcitabine CTRPv2 pan-cancer AAC 0.059 0.07
mRNA Doxorubicin GDSC1000 pan-cancer AAC -0.063 0.08
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.061 0.08
mRNA YM-155 GDSC1000 pan-cancer AAC -0.059 0.08
Download CSV